Safety and efficacy of combined use of low molecular weight heparin (enoxaparin, lovenox) and glycoprotein IIb/IIIa receptor antagonist (eptifibatide, integrelin) during nonemergent coronary and peripheral vascular intervention.
Autor: | Khosla S, Kunjummen B, Guerrero M, Manda R, Razminia M, Trivedi A, Vidyarthi V, Elbazour M, Ahmed A, Lubell D, Khosla, Sandeep, Kunjummen, Binu, Guerrero, Mayra, Manda, Ravi, Razminia, Mansoor, Trivedi, Atul, Vidyarthi, Vasundhara, Elbazour, Monther, Ahmed, Aziz, Lubell, David |
---|---|
Zdroj: | American Journal of Therapeutics; Nov2002, Vol. 9 Issue 6, p488-491, 4p |
Databáze: | Complementary Index |
Externí odkaz: |